Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have earned a consensus recommendation of “Buy” from the nine research firms that are currently covering the company, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have issued a report on […]
Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Free Report) have earned an average rating of “Buy” from the nine analysts that are currently covering the company, MarketBeat reports. Nine analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have covered the stock in the last year […]
Syndax Pharmaceuticals (NASDAQ:SNDX) Coverage Initiated by Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) in a research report sent to investors on Thursday. The firm issued a sell rating on the stock. A number of other research firms have also commented on SNDX. B. Riley raised their price objective on shares of Syndax Pharmaceuticals from $34.00 to […]
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Lowered to $33 00 at JPMorgan Chase & Co themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.